In this episode, Maya is discussing the pros and cons of the Clinical Trials Information System (CTIS) with the Managing Director of FGK Clinical Research GmbH, Martin Krauss. By background, he is a trained statistician with more than 25 years of experience in the clinical research industry.  They dive deep into the following topics: (1:01) Who is Martin Krauss? (3:34) Has the CTIS improved transparency and centralization in clinical trials? (5:40) What are the strengths of the CTIS? (7:19) What are the weaknesses of the CTIS? (11:12) How does the CTIS help you as a CRO? (14:17) What is the impact of the CTIS on the sponsors? (15:38) Do you receive technical support from the CTIS? (19:19) The UK is outside the CTIS. Is that a plus or a minus for them? (21:18) Development of clinical trials in Europe vs USA (24:30) Martin’s recommendations for working with the CTIS Tune in today and start expanding your knowledge! Maya Zlatanova, CEO of Trialhub Martin Krauss, Managing Director of FGK Clinical Research GmbH See More: TrialHub FGK Clinical Research GmbH